Remove Allergies Remove Gene Sequencing Remove Vaccination
article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

It also won a £113 million contract to provide rapid saliva-based COVID-19 testing services to the NHS, although that was ended early by the UK government in the summer as demand fell due to vaccinations.